NeurAxis, Inc.
NRXS · NASDAQ
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Valuation | ||||
| PEG Ratio | 0.04 | -0.00 | 1.31 | 0.47 |
| FCF Yield | -37.68% | -40.25% | -4.67% | -6.92% |
| EV / EBITDA | -1.65 | -1.84 | -11.75 | -10.97 |
| Quality | ||||
| ROIC | -281.64% | 565.28% | 67.79% | 768.67% |
| Gross Margin | 86.52% | 87.67% | 88.94% | 82.81% |
| Cash Conversion Ratio | 0.74 | 0.46 | 0.48 | 0.74 |
| Growth | ||||
| Revenue 3-Year CAGR | 0.01% | -3.31% | 11.63% | 1,396,026.37% |
| Free Cash Flow Growth | 9.46% | -186.78% | -5.52% | 46.35% |
| Safety | ||||
| Net Debt / EBITDA | 0.41 | -0.02 | -0.08 | -0.04 |
| Interest Coverage | -23.80 | -1.24 | -8.08 | -80.43 |
| Efficiency | ||||
| Inventory Turnover | 8.17 | 14.30 | 6.17 | 11.94 |
| Cash Conversion Cycle | -523.95 | -1,412.59 | -1,873.39 | -331.55 |